Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term

Summary by Seeking Alpha
Abbott stays a buy after Q2 beat/raise; Exact Sciences boosts growth. Click for more on ABT stock.

1 Articles

Seeking AlphaSeeking Alpha
Lean Right

Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term

Abbott stays a buy after Q2 beat/raise; Exact Sciences boosts growth. Click for more on ABT stock.

·Ra'anana, Israel
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Wednesday, August 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Abbott Laboratories icon

Abbott Laboratories

Science icon

Science

Stock Markets icon

Stock Markets

Illinois icon

Illinois

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal